Could Preventing Thromboembolism be a New Hope for COVID-19 Patients?

Marcos Roberto Tovani-Palone; Lorenzo Storari; Valerio Barbari

doi:10.29333/ejgm/8244

Full Text (PDF)

Marcos Roberto Tovani-Palone ¹ ² ^* , Lorenzo Storari ³, Valerio Barbari ³

More Detail

¹ Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, BRAZIL² Modestum Ltd, UK³ Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova - Campus of Savona, Savona, ITALY^* Corresponding Author

Abstract

Several researches have been conducted in order to study treatment effects for COVID-19. Nevertheless, some of the current treatments have not been effective or recommended for severe cases. In this perspective article, we briefly discuss the latest developments in the COVID-19 management.

Keywords

COVID-19
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
pandemics
anticoagulants

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Perspective Article

ELECTRON J GEN MED, Volume 17, Issue 6, December 2020, Article No: em250

https://doi.org/10.29333/ejgm/8244

Publication date: 07 May 2020

Article Views: 3663

Article Downloads: 2317

Open Access Disclosures References How to cite this article

Disclosure

Declaration of Conflict of Interest: No conflict of interest is declared by author(s).

References

World Health Organization. Coronavirus disease 2019 (COVID-19). Situation report – 70 [Internet]. Genebra: World Health Organization; 2020. Available at: https://apps.who.int/iris/bitstream/handle/10665/331683/nCoVsitrep30Mar2020-eng.pdf (Accessed: 26 April 2020).
Santacroce L, Charitos IA, Del Prete R. COVID-19 in Italy: an overview from the first case to date. Electron J Gen Med. 2020;17(6):em235. https://doi.org/10.29333/ejgm/7926
Minh Duc N, Duc Ha H, Anh Tuan T, Lien Bang MT, Hong Duc P, Minh Thong P. From first COVID-19 case to current outbreak: a vietnamese report. Electron J Gen Med. 2020;17(4):em208. https://doi.org/10.29333/ejgm/7867
Li LQ, Huang T, Wang YQ, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020. [Epub ahead of print]. https://doi.org/10.1002/jmv.25757 PMid:32162702
Deng Y, Liu W, Liu K, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020. https://doi.org/10.1097/CM9.0000000000000824 PMid:32209890
Johns Hopkins Coronavirus Resource Center. World Map [Internet]. Baltimore. Available at: https://coronavirus.jhu.edu/map.html (Accessed: 26 April 2020).
Remuzzi A, Remuzzi G. COVID-19 and Italy: what next?. Lancet. 2020;395(10231):1225-8. https://doi.org/10.1016/S0140-6736(20)30627-9
Yezli S, Khan A. COVID-19 social distancing in the Kingdom of Saudi Arabia: bold measures in the face of political, economic, social and religious challenges. Travel Med Infect Dis. 2020:101692. https://doi.org/10.1016/j.tmaid.2020.101692 PMid:32330561 PMCid:PMC7172679
Abd El-Aziz TM, Stockand JD. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status. Infect Genet Evol. 2020;83:104327. https://doi.org/10.1016/j.meegid.2020.104327 PMid:32320825 PMCid:PMC7166307
Borba MGS, Val FFA, Sampaio VS, et al. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA Netw Open. 2020;3(4.23):e208857. https://doi.org/10.1001/jamanetworkopen.2020.8857
Spiezia L, Boscolo A, Poletto F, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. 2020.
Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020. pii: S0735-1097(20)35008-7.
Zhai Z, Li C, Chen Y, et al. Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines.Thromb Haemost. 2020.
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020. https://doi.org/10.1111/jth.14817 PMid:32220112
Casini A, Alberio L, Angelillo-Scherrer A, et al. Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis. Swiss Med Wkly. 2020;150:w20247. https://doi.org/10.4414/smw.2020.20247
Valerio L, de Balanzó X, Jiménez O, Pedro-Botet ML. Haemorrhagic exanthema due to dengue virus induced by acetylsalicylic acid. An Sist Sanit Navar. 2006;29(3):439-42. https://doi.org/10.4321/S1137-66272006000500012
Hillegass E, Puthoff M, Frese EM, Thigpen M, Sobush DC, Auten B. Role of physical therapists in the management of individuals at risk for or diagnosed with venous thromboembolism: evidence-based clinical practice guideline. Phys Ther. 2016;96(2):143-66. https://doi.org/10.2522/ptj.20150264 PMid:26515263
Okumuş G, Özçelik B, Sasani H, et al. Do appropriate thromboprophylaxis and routine physiotherapy prevent venous thromboembolism in intensive care unit?. Turk Gogus Kalp Dama. 2015;23(1):92-7. https://doi.org/10.5606/tgkdc.dergisi.2015.9440
Lazzeri M, Lanza A, Bellini R, et al. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a position paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020;90(1):1285. https://doi.org/10.4081/monaldi.2020.1285 PMid:32236089
Ceravolo MG, De Sire A, Andrenelli E, Negrini F, Negrini S. Systematic rapid “living” review on rehabilitation needs due to COVID-19: update to march 31st 2020. Eur J Phys Rehabil Med. 2020. https://doi.org/10.23736/S1973-9087.20.06329-7 PMid:32316718
Thomas P, Baldwin C, Bissett B, et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020. https://doi.org/10.1016/j.jphys.2020.03.011 PMid:32312646 PMCid:PMC7165238
World Health Organization. Coronavirus disease 2019 (COVID-19). Situation report – 72 [Internet]. Genebra: World Health Organization; 2020. Available at: https://apps.who.int/iris/bitstream/handle/10665/331685/nCoVsitrep01Apr2020-eng.pdf (Accessed: 26 April 2020).

How to cite this article

Vancouver

Tovani-Palone MR, Storari L, Barbari V. Could Preventing Thromboembolism be a New Hope for COVID-19 Patients?. ELECTRON J GEN MED. 2020;17(6):em250. https://doi.org/10.29333/ejgm/8244

APA

Tovani-Palone, M. R., Storari, L., & Barbari, V. (2020). Could Preventing Thromboembolism be a New Hope for COVID-19 Patients?. Electronic Journal of General Medicine, 17(6), em250. https://doi.org/10.29333/ejgm/8244

AMA

Tovani-Palone MR, Storari L, Barbari V. Could Preventing Thromboembolism be a New Hope for COVID-19 Patients?. ELECTRON J GEN MED. 2020;17(6), em250. https://doi.org/10.29333/ejgm/8244

Chicago

Tovani-Palone, Marcos Roberto, Lorenzo Storari, and Valerio Barbari. "Could Preventing Thromboembolism be a New Hope for COVID-19 Patients?". Electronic Journal of General Medicine 2020 17 no. 6 (2020): em250. https://doi.org/10.29333/ejgm/8244

Harvard

Tovani-Palone, M. R., Storari, L., and Barbari, V. (2020). Could Preventing Thromboembolism be a New Hope for COVID-19 Patients?. Electronic Journal of General Medicine, 17(6), em250. https://doi.org/10.29333/ejgm/8244

MLA

Tovani-Palone, Marcos Roberto et al. "Could Preventing Thromboembolism be a New Hope for COVID-19 Patients?". Electronic Journal of General Medicine, vol. 17, no. 6, 2020, em250. https://doi.org/10.29333/ejgm/8244